Skip to main content
. 2002 Aug 1;87(3):281–288. doi: 10.1038/sj.bjc.6600450

Figure 2.

Figure 2

Relapse-free survival for stage II, IIIA and IIIB high-risk breast cancer patients treated with HDCT (solid lines) vs standard adjuvant therapy (dotted lines).